Interpace Biosciences Inc. (IDXG): You've got a low float and low O/S AROUN...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Interpace Biosciences Inc. (IDXG)

Reply Private New

Keep Last Read

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	45
Posts	3398
Boards Moderated	0
Alias Born	12/07/2003

Re: UP Trend post# 103

Monday, 11/28/2016 9:14:37 AM

Monday, November 28, 2016 9:14:37 AM

You've got a low float and low O/S AROUND 18 million ... Earnings were good and showing improvement/revenue over 1 million a month.

R/S fears possibly over done in this case,if they do a R/S ... Say 1:10 the O/S would go to 1.8 million LOL! Price currently to 2.80ish ... Plus they say cash flow positive in 2nd have of 2017 So if you start putting the pieces together I suspect it was just undervalued,but not certain where that value lies ... over a dollar isn't impossible here due to above factors.Oh yes and as mentioned probably some short covering added in.

We all know many stocks who aren't cash flow positive and have a huge O/S that are trading higher.We'll see what happens ... kind of curious.

"Diversification is a protection against ignorance. It makes very little sense for those who know what they're doing."

Keep Last Read

Replies (2) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent IDXG News

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:01:48 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 11:33:32 AM
Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:05:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 09:05:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 10:14:32 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 09:16:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:05:18 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/22/2023 08:53:38 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/22/2023 08:20:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2023 07:47:52 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 05:27:44 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2023 09:24:47 PM

More IDXG News

InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow